Abstract
Purpose
This is a secondary analysis of a multi-site, cluster (site) randomized trial of the efficacy of a combined Health and Wellness Cognitive Behavior Therapy (H&W CBT) and medication management approach for depression in youth with HIV (YWH) compared to standard care. In this study, we explored the association between H&W CBT factors and depression outcomes after 24 weeks of treatment to discover treatment elements associated with symptom reduction.
Methods
Participants (12–24 years of age) were YWH in the United States (US) diagnosed with moderate to severe depression [Quick Inventory of Depressive Symptomatology (QIDS), Clinician-Rated score ≥ 11]. Thirteen US sites were randomly assigned to either the combination treatment approach or standard care. For site-level analyses, site-specific summary scores were used to account for the within site correlation.
Results (all scores are site-level)
The number of depressive symptoms [QIDS-Self Reported (QIDS-SR) score] after 24 weeks of H&W CBT was significantly negatively correlated with the mean total session duration (ρ = − 0.94), the total homework assigned (ρ = − 0.83), the total number of practice modules used (ρ = − 0.83), and the mean total booster sessions given (ρ = − 0.82).
Conclusions
Specific elements of the H&W CBT (e.g., dose, assignment of homework, greater skills practice, and use of booster sessions) were associated with improvement of depression outcomes in YWH. A focus on these elements in treatment may improve symptom reduction for YWH with depression.
Similar content being viewed by others
References
Benton, T. D., Kee Ng, W. Y., Leung, D., Canetti, A., & Karnik, N. (2019). Depression among youth living with HIV/AIDS. Child and Adolescent Psychiatric Clinics of North America, 28(3), 447–459. https://doi.org/10.1016/j.chc.2019.02.014
Bernstein, I. H., JohnRush, A., Trivedi, M. H., Hughes, C. W., Macleod, L., Witte, B. P., Jain, S., Mayes, T. L., & Emslie, G. J. (2010). Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents. International Journal of Methods in Psychiatric Research, 19(4), 185–194. https://doi.org/10.1002/mpr.321
Brown, L. K., Chernoff, M., Kennard, B. D., Emslie, G. J., Lypen, K., Buisson, S., Weinberg, A., Whiteley, L. B., Traite, S., Krotje, C., Harriff, L., Townley, E., Bunch, A., Purswani, M., Shaw, R., Spector, S. A., Agwu, A., Shapiro, D. E., IMPAACT 2002 team. (2021). Site-randomized controlled trial of a combined cognitive behavioral therapy and a medication management algorithm for treatment of depression among youth living with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes, 88(5), 497–505. https://doi.org/10.1097/QAI.0000000000002790
Brown, L. K., Whiteley, L., Harper, G. W., Nichols, S., Nieves, A., ATN 086 Protocol Team for The Adolescent Medicine Trials Network for HIV/AIDS Interventions. (2015). Psychological symptoms among 2032 youth living with HIV: A multisite study. AIDS Patient Care and STDs, 29(4), 212–219. https://doi.org/10.1089/apc.2014.0113
Diamond, G., Diamond, G. M., & Levy, S. (2021). Attachment-based family therapy: Theory, clinical model, outcomes, and process research. Journal of Affective Disorders, 294, 286–295. https://doi.org/10.1016/j.jad.2021.07.005
Donenberg, G. R., Fitts, J., Ingabire, C., Nsanzimana, S., Fabri, M., Emerson, E., Remera, E., Manzi, O., Bray, B., & Cohen, M. H. (2022). Results of the Kigali Imbereheza Project: A 2-Arm individually randomized trial of TI-CBT enhanced to address ART adherence and mental health for Rwandan youth living with HIV. Journal of Acquired Immune Deficiency Syndromes, 90(1), 69–78. https://doi.org/10.1097/QAI.0000000000002911
Emslie, G. J., Brister, T., Chapman, M., Dulcan, M. K., Galanter, C. A., Jones, J. M., Kennard, B., Pavlon-Blum, J., Petti, T. A., Robb, A. S., & Wilens, T. E. (2019). Depression Parents’ Medication Guide. American Academy of Child & Adolescent Psychiatry.
Glasgow, R. E., Lichtenstein, E., & Marcus, A. C. (2003). Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. American Journal of Public Health, 93, 1261–1267.
Hayes, R. J., & Moulton, L. H. (2017). Cluster randomised trials (2nd ed.). CRC Press. https://doi.org/10.4324/9781315370286
Kennard, B. D., Brown, L. T., Hawkins, L., Risi, A., Radcliffe, J., Emslie, G. J., Mayes, T. L., King, J. D., Foxwell, A. A., Buyukdura, J., Bethel, J., Naar-King, S., Xu, J., Lee, S. S., Garvie, P., London, C., Tanney, M., & Thornton, S. (2014). Development and implementation of health and wellness CBT for individuals with depression and HIV. Cognitive and Behavioral Practice, 21(2), 237–246. https://doi.org/10.1016/j.cbpra.2013.07.003
Kennard, B. D., Clarke, G. N., RobinWeersing, V., Asarnow, J. R., Shamseddeen, W., Porta, G., Berk, M., Hughes, J. L., Spirito, A., Emslie, G. J., Keller, M. B., Wagner, K. D., & Brent, D. A. (2009). Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: Preliminary findings. Journal of Consulting and Clinical Psychology, 77(6), 1033–1041. https://doi.org/10.1037/a0017411
Klimek, P., Wilhelm, S., Safren, S. A., & Blashill, A. J. (2020). Cognitive Behavioral Therapy for Body Image and Self-Care (CBT-BISC) among sexual minority men living with HIV: Skills-based treatment mediators. Cognitive Therapy and Research, 44(1), 208–215. https://doi.org/10.1007/s10608-019-10035-w
Lewinsohn, P. M., Clarke, G. N., Hops, H., & Andrews, J. (1990). Cognitive-behavioral treatment for depressed adolescents. Behavior Therapy, 21(4), 385–401. https://doi.org/10.1016/S0005-7894(05)80353-3
Lynn, C., Chenneville, T., Bradley-Klug, K., Walsh, A. S. J., Dedrick, R. F., & Rodriguez, C. A. (2019). Depression, anxiety, and posttraumatic stress as predictors of immune functioning: Differences between youth with behaviorally and perinatally acquired HIV. AIDS Care, 31(10), 1261–1270. https://doi.org/10.1080/09540121.2019.1587354
Mufson, L., Dorta, K. P., Wickramaratne, P., Nomura, Y., Olfson, M., & Weissman, M. M. (2004). A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 61(6), 577–584. https://doi.org/10.1001/archpsyc.61.6.577
Qin, K., Zeng, J., Liu, L., & Cai, Y. (2022). Effects of cognitive behavioral therapy on improving depressive symptoms and increasing adherence to antiretroviral medication in people with HIV. Frontiers in Psychiatry, 13, 990994. https://doi.org/10.3389/fpsyt.2022.990994
Work Group on HIV/AIDS. (2000). Practice guideline for the treatment of patients with HIV/AIDS. American Psychiatric Association. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/hivaids-1410197669347.pdf
Work Group on Major Depressive Disorder. (2010). Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. American Psychiatric Association. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf
Zuckerbrot, R. A., Cheung, A., Jensen, P. S., Stein, R. E. K., Laraque, D., GLAD-PC STEERING GROUP. (2018). Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics, 141(3), e20174081. https://doi.org/10.1542/peds.2017-4081
Acknowledgements
We gratefully acknowledge the contributions of the site investigators and staff who conducted the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network’s IMPAACT 2002 study across the United States: BronxCare Health System, Bronx, NY: Luz Holguin, LMSW; Marvin Alvarado, MD; Martha Cavallo, CPNP; Mahboobullah Mirza Baig, MBBS. Jacobi Medical Center, Bronx, NY: Michael G. Rosenberg, MD, PhD; Marlene Burey, NP; Raphaelle Auguste, RN, BSN. University of Colorado School of Medicine, Children’s Hospital Colorado, Denver, CO: Daniel Reirden, MD; Kim Pierce DNP, RN, CPNP; Carrie Chambers BSN, RN; Christine Kwon, BS. University of California, San Diego, CA: Sharon Nichols, PhD; Veronica, Figueroa, M.S; Megan Loughran, B.A. Johns Hopkins University, Baltimore, MD: Mary Anne Knott-Grasso, CRNP; Aleisha Collinson-Streng, RN, BSN; Thuy Anderson, RN, BSN; Bonnie Addison, BA. David Geffen School of Medicine at the University of California, Los Angeles, CA: Jaime G. Deville, MD; Michele F. Carter, RN; Shellye Jones, LCSW; Patricia Tan, PhD. Rush University Cook County Hospital, Chicago, IL: Mariam Aziz, MD; Maureen McNichols RN, MS, CRC; Ixchell Ortiz Estes, NP; Katy Howe, LCSW. Children’s Diagnostic and Treatment Center, Fort. Lauderdale, FL: Lisa-Gaye Robinson, MD, MPH; Patricia A. Garvie, PhD; Kathleen Graham, PharmD; Hanna Major-Wilson, ARNP. Emory University School of Medicine, Atlanta, GA: Andres Camacho-Gonzalez, MD, MSc; Chanda Graves, PhD; LaTeshia Thomas-Seaton, MS, APRN; Nisha George, MPH. St. Jude Children’s Research Hospital, Memphis, TN: Megan L. Wilkins, PhD; Colin Quillivan, MS; Shelley Ost, MD; Sandra Jones, DNP. Texas Children’s Hospital/Baylor College of Medicine, Houston, TX: Mary Paul, MD; Chivon McMullen-Jackson, RN, BSN, CCRP; Kathy Pitts, PhD, APRN, CPNP, MPH; Terry Raburn, RN. Stony Brook Medicine, Stony Brook, NY: Sharon Nachman, MD; Allison Eliscu, MD; Melissa Shikora, LMSW; Barsha Chakraborty. Los Angeles County and University of Southern California Medical Center, Keck School of Medicine, Alhambra, CA: Yvonne Morales, LVN; LaShonda Spencer, MD; Allison Bearden, MD.
Funding
Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH), all components of the National Institutes of Health (NIH), under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), and by NICHD contract number HHSN275201800001I. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Kennard has research support from American Foundation for Suicide Prevention, National Institutes of Health, Patient-Centered Outcomes Research Institute, and the State of Texas. Dr. Kennard receives royalties from Guilford Press and is on the board of the Jerry M. Lewis MD Research Foundation and the George G. and Alva Hudson Smith Foundation. Dr. Emslie is a consultant for Lundbeck, Neuronetics, and Otsuka, and he receives research support from American Foundation for Suicide Prevention, Janssen Research & Development, LLC, National Institutes of Health, Patient-Centered Research Outcomes Institute (PCORI), and the State of Texas. Dr. Baltrusaitis and Dr. Shapiro have research support (to their institution) from National Institutes of Health (for this study) and from ViiV/GSK and Gilead (for other IMPAACT studies). Larry K. Brown, Miriam Chernoff, Jessica Jones, Sarah Buisson, Jaime Deville, Megan Wilkins, Amber Bunch, Chivon McMullen Jackson, Christy Beneri declare that they have no conflict of interest.
Research Involving Human and Animal Participants
No animal studies were carried out by the authors for this article.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (national and institutional).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kennard, B.D., Brown, L.K., Baltrusaitis, K. et al. Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV. Cogn Ther Res (2024). https://doi.org/10.1007/s10608-024-10474-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s10608-024-10474-0